An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge

Journal of Virology

Volumn 71, Issue 11, 1997, Pages 8531-8541

  Buge, S L ^a   Richardson, E ^a   Alipanah, S ^a   Markham, P ^b   Cheng, S ^c   Kalyan, N ^d   Miller, C J ^e   Lubeck, M ^f   Udem, S ^d   Eldridge, J ^g   Robert Guroff, M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

^c WYETH AYERST RESEARCH   (United States)

^d PFIZER INC   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Wyeth Lederle Vaccines and Pediat   (United States)

^g Lederle Praxis Biologicals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 140; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOLOGICAL ADJUVANT; NEUTRALIZING ANTIBODY; RECOMBINANT VACCINE; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS DNA; VIRUS ENVELOPE PROTEIN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENVELOPE GENE; FEMALE; HUMORAL IMMUNITY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; INTRATRACHEAL DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MUCOSAL IMMUNITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VACCINE PRODUCTION; VIRUS MUTANT; VIRUS RECOMBINANT;

EID: 0030798489     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.11.8531-8541.1997     Document Type: Article

References (60)

1. Abimiku, A. G., M. Robert-Guroff, J. Benson, J. Tartaglia, E. Paoletti, R. C. Gallo, P. D. Markham, and G. Franchini. 1997. Long-term survival of SIV-mac251-infected macaques previously immunized with NYVAC-SIV vaccines. J. Acquired Immune Defic. Syndr. 15(Suppl. 1):578-585.
2. Alexander, N. J. 1990. Sexual transmission of human immunodeficiency virus: virus entry into the male and female genital tract. Fertil. Steril. 54:1-18.
3. Alley, C. D., and J. Mestecky. 1988. The mucosal immune system, p. 222-254. In G. Bird and J. E. Calvert (ed.). B lymphocytes in human disease. Oxford University Press, Oxford, England.
4. Berman, P. W., T. J. Gregory, L. Riddle, G. R. Nakamura, M. A. Champe, J. P. Porter, F. M. Wurm, R. D. Hershberg, E. K. Cobb, and J. W. Eichberg. 1990. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature (London) 345: 622-625.
5. Boom, R., C. J. Sol, M. M. Salimans, C. L. Jansen, P. M. Wertheim-van Dillen, and J. Van der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
6. Chakrabarti, S., K. Brechling, and B. Moss. 1985. Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403-3409.
7. Cheng, S., S. Lee, M. Ronchetti-Blume, K. P. Virk, S. Mizutani, J. W. Eichberg, A. Davis, P. P. Hung, V. M. Hirsch, R. M. Chanock, R. H. Purcell, and P. R. Johnson. 1992. Coexpression of the simian immunodeficiency virus Env and Rev proteins by a recombinant human adenovirus host range mutant. J. Virol. 66:6721-6725.
8. Chengalvala, M., M. D. Lubeck, A. R. Davis, S. Mizutani, K. Molner-Kimber, J. Morin, and P. P. Hung. 1991. Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs. Vaccine 9:485-489.
9. Clumeck, N., J. Sonnet, H. Taelman, F. Mascart-Lemone, M. De Bruyere, P. Vandeperre, J. Dasnoy, L. Marcelis, M. Lamy, C. Jonas, L. Eyckmans, H. Noel, M. Vanhaeverbeek, and J.-P. Butzler. 1984. Acquired immunodeficiency syndrome in African patients. N. Engl. J. Med. 310:492-497.
10. Conley, M. E., and D. L. Delacroix. 1987. Intravascular and mucosal immunoglobulin A: two separate but related systems of immune defense? Ann. Intern. Med. 106:892-899.
11. Couch, R. B., R. M. Chanock, T. R. Cate, D. J. Lang, V. Knight, and R. J. Huebner. 1963. Immunization with types 4 and 7 adenovirus by selective infection of the intestinal tract. Am. Rev. Respir. Dis. 88:394-403.
12. Davis, A. R., B. Kostek, B. B. Mason, C. L. Hsiao, J. Morin, S. K. Dheer, and P. P. Hung. 1985. Expression of hepatitis B surface antigen with a recombinant adenovirus. Proc. Natl. Acad. Sci. USA 82:7560-7564.
13. deSchryver, A., and A. Meheus. 1990. Epidemiology of sexually transmitted diseases: the global picture. Bull. W.H.O. 68:639-654.
14. Dewar, R. L., V. Natarajan, M. B. Vasudevachari, and N. P. Salzman. 1989. Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus. J. Virol. 63:129-136.
15. Forrest, B. D. 1992. The need for consideration of mucosal immunity in vaccine approaches to AIDS. Vaccine Res. 1:137.
16. Franchini, G., P. D. Markham, E. Gard, K. Fargnoli, S. Keubaruwa, L. Jagodzinski, M. Robert-Guroff, P. Lusso, G. Ford, F. Wong-Staal, and R. C. Gallo. 1990. Persistent infection of rhesus macaques with a molecular clone of human immunodeficiency virus type 2: evidence of minimal genetic drift and low pathogenic effects. J. Virol. 64:4462-4467.
17. Franklin, J. T., Jr., E. L. Buscher, W. H. Bancroft, and P. K. Russel. 1971. Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J. Infect. Dis. 124:155-160.
18. Hirsch, V. M., T. R. Fuerst, G. Sulter, M. W. Carroll, L. C. Yang, S. Goldstein, M. Piatak, Jr., W. R. Elkins, W. G. Alvoid, D. C. Montefiori, B. Moss, and J. D. Lifson. 1996. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J. Virol. 70:3741-3752.
19. Hospedales, J. 1989. Heterosexual spread of HIV infection. Rev. Infect. Dis. 11:663-665.
20. Hu, S. L., K. Abrams, G. N. Barber, P. Moran, J. M. Zarling, A. J. Langlois, L. Kuller, W. R. Morton, and R. E. Benveniste. 1992. Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science 255:456-459.
21. Johnson, A. M. 1988. Heterosexual transmission of human immunodeficiency virus. Br. Med. J. 296:1017-1020.
22. Kalyanaraman, V. S., V. Rodriguez, F. Veronese, R. Rahman, P. Lusso, A. L. De Vico, T. Copeland, S. Oroszlan, R. C. Gallo, and M. G. Sarngadharan. 1990. Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 6:371-380.
23. Kanki, P. J., J. Alroy, and M. Essex. 1985. Isolation of T-lymphotropic retroviruses related to HTLV-III/LAV from wild-caught African green monkeys. Science 230:951-954.
24. + cells by simian immunodeficiency virus: productive infection associated with envelope glycoprotein-induced fusion. Proc. Natl. Acad. Sci. USA 86:2443-2447.
25. Koplan, J. P., J. R. Allen, and A. M. Hardy. 1986. Epidemiology of the acquired immunodeficiency syndrome in intravenous drug users. Adv. Alcohol Subst. Abuse 5:13-23.
26. Kozlowski, P. A., K. P. Black, L. Shen, and S. Jackson. 1995. High prevalence of serum IgA HIV-1 infection-enhancing antibodies in HIV-infected persons. J. Immunol. 154:6163-6173.
27. Kreiss, J. K., D. Koech, F. A. Plummer, K. K. Holmes, M. Lightfoote, P. Piot, A. R. Ronald, J. O. Ndinya-Achola, L. J. D'Costa, P. Roberts, E. N. Ngugi, and T. C. Quinn. 1986. AIDS virus infection in Nairobi prostitutes: spread of the epidemic to East Africa. N. Engl. J. Med. 314:414-418.
28. Lange, J. M., H. vanden Berg, L. J. Dooren, J. M. Voosen, E. Kuis, and J. Goudsmit. 1986. HTLV-III/LAV infection in nine children infected by a single plasma donor: clinical outcome and recognition patterns of viral proteins. J. Infect. Dis. 154:171-174.
29. Lehner, T., L. A. Bergmeier, L. Tao, C. Panagiotidi, L. S. Klavinski, L. Hussain, R. G. Ward, N. Meyers, S. E. Adams, A. J. H. Gearing, and R. Brookes. 1994. Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal, and urinary immune responses in nonhuman primates. J. Immunol. 153:1858-1868.
30. Lehner, T., L. Tao, C. Panagiotidi, L. S. Klavinski, R. Brookes, L. Hussain, N. Meyers, S. E. Adams, A. J. Gearing, and L. A. Bergmeier. 1994. Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen. J. Virol. 68:1624-32.
31. Lehner, T., Y. Wang, M. Cranage, L. A. Bergmeier, E. Mitchell, L. Tao, G. Hall, M. Dennis, N. Cook, R. Brookes, L. Klavinskis, I. Jones, C. Doyle, and R. Ward. 1996. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat. Med. 2:767-775.
32. Lohman, B. L., M. B. McChesney, C. J. Miller, E. Mcgowan, S. M. Joye, K. K. A. Van Rompay, E. Reay, L. Antipa, N. C. Pedersen, and M. L. Marthas. 1994. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J. Virol. 68:7021-7029.
33. Lohman, B. L., M. B. McChesney, C. J. Miller, M. Otsyula, C. J. Berardi, and M. L. Marthas. 1994. Mucosal immunization with a live, virulence-attenuated simian immunodeficiency virus (SIV) vaccine elicits antiviral cytotoxic T lymphocytes and antibodies in rhesus macaques. J. Med. Primatol. 23:95-101.
34. Lubeck, M. D., R. J. Natuk, M. Chengalvala, P. K. Chanda, K. K. Murthy, S. Murthy, S. Mizutani, S. G. Lee, M. S. Wade, B. M. Bhat, R. Bhat, S. K. Dheer, J. W. Eichberg, A. R. Davis, and P. P. Hung. 1994. Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. AIDS Res. Hum. Retroviruses 10:1443-9.
35. Lubeck, M. D., R. J. Natuk, M. Myagkikh, N. Kalyan, K. Aldrich, F. Sinangil, S. Alipanah, S. C. S. Murthy, P. K. Chanda, S. Nigida, P. D. Markham, S. Zolla-Pazner, K. Steimer, M. Wade, M. S. Reitz, Jr., L. O. Arthur, S. Mizutani, A. Davis, P. Hung, R. C. Gallo, J. Eichberg, and M. Robert-Guroff. 1997. Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization. Nat. Med. 3:651-658.
36. Marthas, M. L., C. J. Miller, S. Sutjiplo, J. Higgins, J. Torten, B. L. Lohman, R. E. Unger, R. A. Ramos, H. Kiyono, J. R. McGhee, P. A. Marx, and N. C. Pedersen. 1992. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV. J. Med. Primatol. 21:99-107.
37. Marx, P. A., R. W. Compans, A. Gettie, J. K. Staas, R. M. Gilley, M. J. Mulligan, G. V. Yamshchikov, D. Chen, and J. H. Eldridge. 1993. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260:1323-1327.
38. Mestecky, J., W. H. Kutteh, and S. Jackson. 1994. Mucosal immunity in the female genital tract: relevance to vaccination efforts against the human immunodeficiency virus. AIDS Res. Hum. Retroviruses 10(Suppl. 2):S11-S20.
39. Mestecky, J., and J. R. McGhee. 1987. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 40:153-245.
40. Miller, C. J. Unpublished data.
41. Miller, C. J., M. Marthas, J. Torten, N. J. Alexander, J. P. Moore, G. F. Doncel, and A. G. Hendrickx. 1994. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J. Virol. 68:6391-6400.
42. Miller, C. J., M. B. McChesney, X. Lu, P. J. Dailey, C. Chutdowski, D. Lu, P. Brosio, B. Roberts, and Y. Lu. 1997. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J. Virol. 71:1911-1921.
43. Myers, G., B. Korber, B. Foley, K.-T. Jeang, J. W. Mellors, and S. Wain-Hobson. 1996. Human retroviruses and AIDS 1996. Los Alamos National Laboratory, Los Alamos, N. Mex.
44. Natuk, R. J., P. K. Chanda, M. D. Lubeck, A. R. Davis, J. Wilhelm, R. Hjorth, M. S. Wade, B. M. Bhat, S. Mizutani, S. Lee, J. W. Eichberg, R. C. Gallo, P. P. Hung, and M. Robert-Guroff. 1992. Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titered HIV-neutralizing antibodies in the dog model. Proc. Natl. Acad. Sci. USA 89:7777-7781.
45. Natuk, R. J., A. R. Davis, P. K. Chanda, M. D. Lubeck, M. Chengalvala, S. C. Murthy, M. S. Wade, S. K. Dheer, B. M. Bhat, K. K. Murthy, M. Robert-Guroff, S. Mizutani, S.-G. Lee, J. W. Eichberg, R. C. Gallo, and P. P. Hung. 1994. Adenovirus vectored vaccines. Dev. Biol. Stand. 82:71-77.
46. Natuk, R. J., M. D. Lubeck, P. K. Chanda, M. Chengalvala, M. S. Wade, S. C. Murthy, J. Wilhelm, S. K. Vernon, S. K. Dheer, S. Mizutani, S.-G. Lee, K. K. Murthy, J. W. Eichberg, A. R. Davis, and P. P. Hung. 1993. Immunogenicity of recombinant human adenovirus-human immunodeficiency virus vaccines in chimpanzees. AIDS Res. Hum. Retroviruses 9:395-404.
47. Pela, A. O., and J. J. Platt. 1989. AIDS in Africa: emerging trends. Soc. Sci. Med. 28:1-8.
48. Popovic, M., M. G. Sarngadharan, M. Read, and R. C. Gallo. 1984. Detection, isolation, and continuous production of cytopathic human T-lymphotropic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497-500.
49. Prevec, L., B. S. Christie, K. E. Laurie, M. M. S. Bailey, F. L. Graham, and K. L. Rosenthal. 1991. Immune response to HIV-1 Gag antigens induced by recombinant adenovirus vectors in mice and rhesus macaque monkeys. J. Acquired Immune Defic. Syndr. 4:568-576.
50. Prince, A. M., H. Reesink, D. Pascual, B. Horowitz, I. Hewlett, K. K. Murthy, K. E. Cobb, and J. W. Eichberg. 1991. Prevention of HIV infection by passive immunization with HIV immunoglobulin. AIDS Res. Hum. Retroviruses 7:971-973.
51. Public Health Service. 1986. Public Health Services plan: prevention and control of AIDS and the virus. Public Health Rep. 101:341-348.
52. Quinn, T. C. 1987. AIDS in Africa: evidence for heterosexual transmission of the human immunodeficiency virus. N. Y. State J. Med. 5:286-289.
53. Quinn, T. C., J. M. Mann, J. W. Curran, and P. Piot. 1986. AIDS in Africa: an epidemiological paradigm. Science 234:955-963.
54. Robert-Guroff, M. 1990. Neutralizing antibodies, p. 179-185. In A. Aldovini, and B. D. Walker (ed.), Techniques in HIV research. Stockton Press, New York, N.Y.
55. Romano, J. W., K. G. Williams, R. N. Shurtliff, C. Ginocchio, and M. Kaplan. 1997. NASBA technology: isothermal RNA amplification in qualitative and quantitative diagnostics. Immunol. Invest. 26:15-28.
56. Rubin, B. A., and L. B. Rorke. 1988. Adenovirus vaccines, p. 492-572. In S. A. Plotkin and E. A. Mortimer, Jr. (ed.), Vaccines. W. B. Saunders, Philadelphia, Pa.
57. Schneider, M., F. L. Graham, and L. Prevec. 1989. Expression of the glycoprotein of vesicular stomatitis virus by infectious adenovirus vectors. J. Gen. Virol. 70:417-427.
58. Schumacher, G. B. F. 1980. Humoral immune factors in the female reproductive tract and their changes during the cycle, p. 93-137. In D. Dhindsa and G. B. F. Schumacher (ed.), Immunologic aspects of infertility and fertility regulation. Elsevier North Holland, Amsterdam, The Netherlands.
59. Voss, G., J. Li, K. Manson, M. Wyand, J. Sodroski, and N. L. Letvin. 1995. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus macaques. Virology 208:770-775.
60. Zolla-Pazner, S., M. Lubeck, S. Xu, R. Natuk, F. Sinangil, K. Steimer, R. C. Gallo, J. Eichberg, T. Matthews, and M. Robert-Guroff. Induction of neutralizing antibodies in chimpanzees to T cell line-adapted and primary HIV-1 viruses with a prime/boost vaccine regimen. Submitted for publication.